{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T22:44:35Z","timestamp":1782686675803,"version":"3.54.5"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1038\/s41429-026-00920-4","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T09:51:16Z","timestamp":1775814676000},"page":"469-481","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tuspetinib enhances the activity of polymyxin B by inhibiting the GlcNAc6P deacetylase"],"prefix":"10.1038","volume":"79","author":[{"given":"Yu","family":"Ouyang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqin","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yini","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengpan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xitao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanming","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8569-5184","authenticated-orcid":false,"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"920_CR1","doi-asserted-by":"publisher","first-page":"e179","DOI":"10.1016\/S2666-5247(22)00355-X","volume":"4","author":"BJ Langford","year":"2023","unstructured":"Langford BJ, So M, Simeonova M, Leung V, Lo J, Kan T, et al. Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis. Lancet Microbe. 2023;4:e179\u2013e191.","journal-title":"Lancet Microbe"},{"key":"920_CR2","unstructured":"WHO. Bacterial Priority Pathogens List, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. Geneva: World Health Organization; 2024."},{"key":"920_CR3","doi-asserted-by":"publisher","first-page":"e523","DOI":"10.1093\/cid\/ciaa121","volume":"71","author":"MJ Satlin","year":"2020","unstructured":"Satlin MJ, Lewis JS, Weinstein MP, Patel J, Humphries RM, Kahlmeter G, et al. Clinical and Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing Position Statements on Polymyxin B and Colistin Clinical Breakpoints. Clin Infect Dis. 2020;71:e523\u2013e529.","journal-title":"Clin Infect Dis"},{"key":"920_CR4","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/d41586-024-02601-4","volume":"632","author":"A Dance","year":"2024","unstructured":"Dance A. Five ways science is tackling the antibiotic resistance crisis. Nature. 2024;632:494\u20136.","journal-title":"Nature"},{"key":"920_CR5","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.00109-24","volume":"9","author":"Y Huang","year":"2024","unstructured":"Huang Y, Zhu Y, Yue H-Y, Liu Y-Y, Deng L-M, Lv L, et al. Flavomycin restores colistin susceptibility in multidrug-resistant Gram-negative bacteria. mSystems. 2024;9:e0010924.","journal-title":"mSystems"},{"key":"920_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2024.107233","volume":"64","author":"S Liu","year":"2024","unstructured":"Liu S, Zhou H, Kong J, Chen H, Chen L, Tang M, et al. Verapamil increases susceptibility of colistin-resistant Acinetobacter baumannii to colistin. Int J Antimicrob Agents. 2024;64:107233.","journal-title":"Int J Antimicrob Agents"},{"key":"920_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-78769-6","volume":"14","author":"M Hussein","year":"2024","unstructured":"Hussein M, Kang Z, Neville SL, Allobawi R, Thrombare V, Koh AJJ, et al. Metabolic profiling unveils enhanced antibacterial synergy of polymyxin B and teixobactin against multidrug-resistant Acinetobacter baumannii. Sci Rep. 2024;14:27145.","journal-title":"Sci Rep"},{"key":"920_CR8","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.3390\/antibiotics13121165","volume":"13","author":"SA Ahmed","year":"2024","unstructured":"Ahmed SA, Jordan RL, Isseroff RR, Lenhard JR. Potential synergy of fluoxetine and antibacterial agents against skin and soft tissue pathogens and drug-resistant organisms. Antibiotics. 2024;13:1165.","journal-title":"Antibiotics"},{"key":"920_CR9","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s10096-025-05044-5","volume":"44","author":"N Khoshdel","year":"2025","unstructured":"Khoshdel N, Noursalehigarakani M, Seghatoleslami ZS, Hadavand F, Eghbal E, Nasiri MJ, et al. Efficacy of Ceftazidime-avibactam in treating gram-negative infections: a systematic review and meta-analysis. Eur J Clin Microbiol Infect Dis. 2025;44:767\u201378.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"920_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2025.117118","volume":"240","author":"L Zhu","year":"2025","unstructured":"Zhu L, Li Z, Yuan Z, Li H, Zhou T, Chen Y, et al. Repurposing antitumor drugs for the treatment of non-oncological diseases: mechanistic insights, clinical evidence, and future perspectives. Biochem Pharmacol. 2025;240:117118.","journal-title":"Biochem Pharmacol"},{"key":"920_CR11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1001\/jama.2025.7710","volume":"334","author":"S Kumar","year":"2025","unstructured":"Kumar S, Tarnow-Mordi W, Mol BW, Flenady V, Liley HG, Badawi N, et al. iSEARCH investigators. intrapartum sildenafil to improve perinatal outcomes: a randomized clinical trial. JAMA. 2025;334:149\u201359.","journal-title":"JAMA"},{"key":"920_CR12","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aai9048","volume":"9","author":"SS Pullamsetti","year":"2017","unstructured":"Pullamsetti SS, Kojonazarov B, Storn S, Gall H, Salazar Y, Wolf J, et al. Lung cancer-associated pulmonary hypertension: Role of microenvironmental inflammation based on tumor cell-immune cell cross-talk. Sci Transl Med. 2017;9:eaai9048.","journal-title":"Sci Transl Med"},{"key":"920_CR13","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2478\/jtim-2022-0027","volume":"10","author":"J Liu","year":"2022","unstructured":"Liu J, Yang P, Tian H, Zhen K, McCabe C, Zhao L, et al. Right ventricle remodeling in chronic thromboembolic pulmonary hypertension. J Transl Int Med. 2022;10:125\u201333.","journal-title":"J Transl Int Med"},{"key":"920_CR14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1158\/2767-9764.CRC-24-0258","volume":"5","author":"H Sonowal","year":"2025","unstructured":"Sonowal H, Rice WG, Bejar R, Byun JY, Jung SH, Sinha R, et al. Preclinical development of tuspetinib for the treatment of acute myeloid leukemia. Cancer Res Commun. 2025;5:74\u201383.","journal-title":"Cancer Res Commun"},{"key":"920_CR15","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1182\/blood-2021-150014","volume":"138","author":"N Daver","year":"2021","unstructured":"Daver N, Lee K, Jung C, Yoon S, Arellano M, Yoon J, et al. First-in-human (FIH) FLT3 and SYK inhibitor HM43239 shows single-agent activity in patients (pts) with relapsed or refractory (R\/R) FLT3-mutated and wild-type acute myeloid leukemia (AML). Blood. 2021;138:702.","journal-title":"Blood"},{"key":"920_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1182\/blood-2020-143244","volume":"136","author":"N Daver","year":"2020","unstructured":"Daver N, Lee K, Jung C, Soo Y, Arellano M, Jonas B, et al. HM43239, a novel small molecule inhibitor of FLT3, in acute myeloid leukemia (AML) with and without FMS-like tyrosine kinase 3 (FLT3) mutations: phase 1\/2 study. Blood. 2020;136:1.","journal-title":"Blood"},{"key":"920_CR17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s00203-011-0752-3","volume":"194","author":"M Popowska","year":"2012","unstructured":"Popowska M, Osi\u0144ska M, Rzeczkowska M. N-acetylglucosamine-6-phosphate deacetylase (NagA) of Listeria monocytogenes EGD, an essential enzyme for the metabolism and recycling of amino sugars. Arch Microbiol. 2012;194:255\u201368.","journal-title":"Arch Microbiol"},{"key":"920_CR18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1128\/MMBR.00027-07","volume":"72","author":"JT Park","year":"2008","unstructured":"Park JT, Uehara T. How bacteria consume their own exoskeletons (turnover and recycling of cell wall peptidoglycan). Microbiol Mol Biol Rev. 2008;72:211\u201327.","journal-title":"Microbiol Mol Biol Rev"},{"key":"920_CR19","doi-asserted-by":"publisher","DOI":"10.1128\/JB.00371-21","volume":"203","author":"EC Keffeler","year":"2021","unstructured":"Keffeler EC, Parthasarathy S, Abdullahi ZH, Hancock LE. Metabolism of Poly-\u03b21,4-N-acetylglucosamine substrates and importation of N-acetylglucosamine and glucosamine by Enterococcus faecalis. J Bacteriol. 2021;203:e0037121.","journal-title":"J Bacteriol"},{"key":"920_CR20","doi-asserted-by":"publisher","first-page":"9770","DOI":"10.1074\/jbc.RA118.002597","volume":"293","author":"MS Ahangar","year":"2018","unstructured":"Ahangar MS, Furze CM, Guy CS, Cooper C, Maskew KS, Graham B, et al. Structural and functional determination of homologs of the Mycobacterium tuberculosis N-acetylglucosamine-6-phosphate deacetylase (NagA). J Biol Chem. 2018;293:9770\u201383.","journal-title":"J Biol Chem"},{"key":"920_CR21","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1016\/S0140-6736(24)00876-6","volume":"403","author":"IN Okeke","year":"2024","unstructured":"Okeke IN, de Kraker MEA, Van Boeckel TP, Kumar CK, Schmitt H, Gales AC, et al. The scope of the antimicrobial resistance challenge. Lancet. 2024;403:2426\u201338.","journal-title":"Lancet"},{"key":"920_CR22","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.idc.2020.08.003","volume":"34","author":"Q Yang","year":"2020","unstructured":"Yang Q, Pogue JM, Li Z, Nation RL, Kaye KS, Li J. Agents of last resort: an update on polymyxin resistance. Infect Dis Clin North Am. 2020;34:723\u201350.","journal-title":"Infect Dis Clin North Am"},{"key":"920_CR23","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/978-3-030-16373-0_18","volume":"1145","author":"MAK Azad","year":"2019","unstructured":"Azad MAK, Nation RL, Velkov T, Li J. Mechanisms of polymyxin-induced nephrotoxicity. Adv Exp Med Biol. 2019;1145:305\u201319.","journal-title":"Adv Exp Med Biol"},{"key":"920_CR24","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1080\/13696998.2018.1552431","volume":"22","author":"FF Tuon","year":"2019","unstructured":"Tuon FF, Rocha JL, Gasparetto J. Polymyxin B and colistin: the economic burden of nephrotoxicity against multidrug-resistant bacteria. J Med Econ. 2019;22:158\u201362.","journal-title":"J Med Econ"},{"key":"920_CR25","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s00018-022-04316-z","volume":"79","author":"J Lu","year":"2022","unstructured":"Lu J, Azad MAK, Moreau JLM, Zhu Y, Jiang X, Tonta M, et al. Inwardly rectifying potassium channels mediate polymyxin-induced nephrotoxicity. Cell Mol Life Sci. 2022;79:296.","journal-title":"Cell Mol Life Sci"},{"key":"920_CR26","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3390\/antibiotics12020415","volume":"12","author":"M Li","year":"2023","unstructured":"Li M, Azad MAK, Thompson PE, Roberts KD, Velkov T, Zhu Y, et al. Transcriptomic responses to polymyxin B and analogues in human kidney tubular cells. Antibiotics. 2023;12:415.","journal-title":"Antibiotics"},{"key":"920_CR27","doi-asserted-by":"publisher","first-page":"342","DOI":"10.2174\/1574886318666230905100924","volume":"19","author":"Y Lisnyak","year":"2024","unstructured":"Lisnyak Y, Martynov A, Farber B. Interactions between antimicrobial peptides and targets responsible for their nephrotoxic action: molecular dynamics simulations. Curr Drug Saf. 2024;19:342\u20139.","journal-title":"Curr Drug Saf"},{"key":"920_CR28","first-page":"1","volume":"17","author":"T Gil-Gil","year":"2024","unstructured":"Gil-Gil T, Laborda P, Mart\u00ednez JL, Hernando-Amado S. Use of adjuvants to improve antibiotic efficacy and reduce the burden of antimicrobial resistance. Expert Rev Anti Infect Ther. 2024;17:1.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"920_CR29","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abb3791","volume":"12","author":"DMP De Oliveira","year":"2020","unstructured":"De Oliveira DMP, Bohlmann L, Conroy T, Jen FE, Everest-Dass A, Hansford KA, et al. Repurposing a neurodegenerative disease drug to treat Gram-negative antibiotic-resistant bacterial sepsis. Sci Transl Med. 2020;12:eabb3791.","journal-title":"Sci Transl Med"},{"key":"920_CR30","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.chembiol.2020.04.005","volume":"27","author":"CN Tsai","year":"2020","unstructured":"Tsai CN, MacNair CR, Cao MPT, Perry JN, Magolan J, Brown ED, et al. Targeting two-component systems uncovers a small-molecule inhibitor of Salmonella virulence. Cell Chem Biol. 2020;27:793\u2013805.","journal-title":"Cell Chem Biol"},{"key":"920_CR31","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1038\/s41564-020-0723-z","volume":"5","author":"M Song","year":"2020","unstructured":"Song M, Liu Y, Huang X, Ding S, Wang Y, Shen J, et al. A broad-spectrum antibiotic adjuvant reverses multidrug-resistant Gram-negative pathogens. Nat Microbiol. 2020;5:1040\u201350.","journal-title":"Nat Microbiol"},{"key":"920_CR32","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1021\/acsinfecdis.9b00419","volume":"6","author":"MA Farha","year":"2020","unstructured":"Farha MA, El-Halfawy OM, Gale RT, MacNair CR, Carfrae LA, Zhang X, et al. Uncovering the hidden antibiotic potential of cannabis. ACS Infect Dis. 2020;6:338\u201346.","journal-title":"ACS Infect Dis"},{"key":"920_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.134670","volume":"278","author":"P Zhang","year":"2024","unstructured":"Zhang P, Zeng P, Lai CKC, Ip M, To KKW, Zuo Z, et al. Synergism of colistin and globular endolysins against multidrug-resistant gram-negative bacteria. Int J Biol Macromol. 2024;278:134670.","journal-title":"Int J Biol Macromol"},{"key":"920_CR34","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1038\/s41564-023-01369-z","volume":"8","author":"LA Carfrae","year":"2023","unstructured":"Carfrae LA, Rachwalski K, French S, Gordzevich R, Seidel L, Tsai CN, et al. Inhibiting fatty acid synthesis overcomes colistin resistance. Nat Microbiol. 2023;8:1026\u201338.","journal-title":"Nat Microbiol"},{"key":"920_CR35","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/s41579-019-0201-x","volume":"17","author":"BW Simpson","year":"2019","unstructured":"Simpson BW, Trent MS. Pushing the envelope: LPS modifications and their consequences. Nat Rev Microbiol. 2019;17:403\u201316.","journal-title":"Nat Rev Microbiol"},{"key":"920_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-02875-z","volume":"9","author":"CR MacNair","year":"2018","unstructured":"MacNair CR, Stokes JM, Carfrae LA, Fiebig-Comyn AA, Coombes BK, Mulvey MR, et al. Overcoming mcr-1-mediated colistin resistance with colistin in combination with other antibiotics. Nat Commun. 2018;9:458.","journal-title":"Nat Commun"},{"key":"920_CR37","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41579-018-0141-x","volume":"17","author":"M Tyers","year":"2019","unstructured":"Tyers M, Wright GD. Drug combinations: a strategy to extend the life of antibiotics in the 21st century. Nat Rev Microbiol. 2019;17:141\u201355.","journal-title":"Nat Rev Microbiol"},{"key":"920_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/INMD.20240081","volume":"3","author":"J Wu","year":"2025","unstructured":"Wu J, Liu Y, Su J, Yang Y, Deng H, Yang Y, et al. Investigation on Klebsiella pneumoniae in the field of extracellular vesicles. Interdiscip Med. 2025;3:e20240081.","journal-title":"Interdiscip Med"},{"key":"920_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49629-8","volume":"15","author":"MJ Cheng","year":"2024","unstructured":"Cheng MJ, Wu YY, Zeng H, Zhang TH, Hu YX, Liu SY, et al. Asymmetric total synthesis of polycyclic xanthenes and discovery of a WalK activator active against MRSA. Nat Commun. 2024;15:5879.","journal-title":"Nat Commun"},{"key":"920_CR40","unstructured":"Clinical and Laboratory Standards Institute [CLSI]. M100 performance standards for antimicrobial susceptibility testing. Clinical and Laboratory Standards Institute; 2024."},{"key":"920_CR41","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1021\/acsinfecdis.3c00591","volume":"10","author":"R Cui","year":"2024","unstructured":"Cui R, Zhang J, Liu X, Hu C, Zhou F, Zhang M, et al. Dronedarone enhances the antibacterial activity of polymyxin B and inhibits the quorum-sensing system by interacting with LuxS. ACS Infect Dis. 2024;10:961\u201370.","journal-title":"ACS Infect Dis"},{"key":"920_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/dkg301","volume":"52","author":"FC Odds","year":"2003","unstructured":"Odds FC. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother. 2003;52:1.","journal-title":"J Antimicrob Chemother"},{"key":"920_CR43","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B Methodol. 1995;57:289\u2013300.","journal-title":"J R Stat Soc B Methodol"},{"key":"920_CR44","doi-asserted-by":"publisher","DOI":"10.1126\/science.1255784","volume":"346","author":"MM Savitski","year":"2014","unstructured":"Savitski MM, Reinhard FB, Franken H, Werner T, Savitski MF, Eberhard D, et al. Tracking cancer drugs in living cells by thermal profiling of the proteome. Science. 2014;346:1255784.","journal-title":"Science"},{"key":"920_CR45","doi-asserted-by":"publisher","first-page":"e01834","DOI":"10.1128\/AEM.01834-18","volume":"84","author":"Y Wang","year":"2018","unstructured":"Wang Y, Wang S, Chen W, Song L, Zhang Y, Shen Z, et al. CRISPR-Cas9 and CRISPR-assisted cytidine deaminase enable precise and efficient genome editing in Klebsiella pneumoniae. Appl Environ Microbiol. 2018;84:e01834\u201318.","journal-title":"Appl Environ Microbiol"},{"key":"920_CR46","doi-asserted-by":"publisher","first-page":"115455","DOI":"10.1016\/j.bcp.2023.115455","volume":"210","author":"H Zeng","year":"2023","unstructured":"Zeng H, Cheng M, Liu J, Hu C, Lin S, Cui R, et al. Pyrimirhodomyrtone inhibits Staphylococcus aureus by affecting the activity of NagA. Biochem Pharmacol. 2023;210:115455.","journal-title":"Biochem Pharmacol"}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41429-026-00920-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-026-00920-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-026-00920-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T22:02:58Z","timestamp":1782684178000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41429-026-00920-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["920"],"URL":"https:\/\/doi.org\/10.1038\/s41429-026-00920-4","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"8 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Animal experiments were performed according to the National Institutes of Health Guide for the Care and Use of Laboratory Animals and approved by the Animal Ethical and Experimental Committee of the Army Military Medical University (approval no. 2011-04).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}